The Covaxin Controversy | Explained by Dhruv Rathee
Published January 3, 2021
This video has 7.37M views and 376K likes, ranking #714,407 globally among tracked YouTube videos by view count.
At a glance
Views
7,379,521
Likes
376,020
Comments
5,828
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
India just approved Covaxin and Covishield vaccines for emergency use in the country. But why are people criticising it? I tried to experiment with the #Shorts format, let me know if you want more of these news shorts. Support my work and join as a member to get exclusive stuff: 1. On Patreon: https://www.patreon.com…
- Published
- January 3, 2021
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.
Frequently asked questions
How accurate are these YouTube video analytics?
View, like, and comment counts come from YouTube's public API and refresh regularly. Growth and revenue figures are estimates built from tracked historical data, so they can differ slightly from what the creator sees privately in YouTube Studio.
What is the outlier score?
How this video's views compare to the channel's usual Shorts or long-form video. A 2x score means double the usual views for that channel, 0.5x means half.
What is engagement rate and how is it calculated?
Likes and comments per view, compared to this channel's typical engagement rate — shown as above or below what's usual for the channel.
How is the revenue estimate calculated?
It's a rough public estimate based on a $0.7–$2.0 CPM (revenue per 1,000 views) applied to view count — not actual creator earnings, which depend on ad rates, audience geography, and monetization settings YouTube doesn't expose publicly.
Is this YouTube video analytics checker free?
Yes. You get 10 free channel and video analytics lookups per rolling hour without an account — logging in, which is also free, removes that limit entirely.